Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mimi I Hu

Showing results (51-60 of 92) with videos related to

Pageof 10
Sort By:
The Journal of Clinical Endocrinology and Metabolism|August 31, 2016
Detection and Prognostic Significance of Circulating Tumor Cells in Patients With Metastatic Thyroid CancerJian Yu Xu, Beverly Handy, Christina L Michaelis, et al.
The Journal of Clinical Endocrinology and Metabolism|March 5, 2024
Pediatric Medullary Thyroid Carcinoma: Clinical Presentations and Long-Term Outcomes in 144 Patients Over 6 DecadesSarah G Hensley, Mimi I Hu, Roland L Bassett, et al.
Head & Neck|November 10, 2020
Neoadjuvant selpercatinib for advanced medullary thyroid cancerYelda Jozaghi, Mark Zafereo, Michelle D Williams, et al.
The Journal of Clinical Endocrinology and Metabolism|June 11, 2014
Denosumab for treatment of hypercalcemia of malignancyMimi I Hu, Ilya G Glezerman, Sophie Leboulleux, et al.
Thyroid : Official Journal of the American Thyroid Association|July 10, 2024
The Multi-Institutional Medullary Thyroid Cancer Collaborative Registry: Can a Rare Tumor Registry Accurately Represent the Real-World Patient Population?Thomas Szabo Yamashita, Sophia M Williams-Perez, Sara Ehsan, et al.
The Journal of Clinical Endocrinology and Metabolism|March 18, 2014
Role of salvage targeted therapy in differentiated thyroid cancer patients who failed first-line sorafenibRamona Dadu, Catherine Devine, Mike Hernandez, et al.
Surgery|December 10, 2025
The shifting landscape of germline RET pathogenic variants with the introduction of panel testingAmblessed E Onuma, Catherine M Skefos, Marcy E Richardson, et al.
Journal of Neuro-Oncology|April 14, 2026
A differentiated thyroid carcinoma-specific graded prognostic assessment for brain metastases: derivation in a 10,306-patient cohort and external validationHamza A Salim, Sarimar Agosto, Heba Al Qudah, et al.
JCO Oncology Practice|December 19, 2025
Increasing Access and Quality Care for Immune Checkpoint Inhibitor-Related Thyroid DysfunctionAnne K Brinkman, Amori Y Salami-Henry, Lori A Aaron-Brija, et al.
Endocrine|July 25, 2015
Preexisting adrenal masses in patients with adrenocortical carcinoma: clinical and radiological factors contributing to delayed diagnosisLevent Ozsari, Merve Kutahyalioglu, Khaled M Elsayes, et al.
Pageof 10

Showing results (51-60 of 92) with videos related to

Sort By:
Pageof 10
The Journal of Clinical Endocrinology and Metabolism|August 31, 2016
Detection and Prognostic Significance of Circulating Tumor Cells in Patients With Metastatic Thyroid CancerJian Yu Xu, Beverly Handy, Christina L Michaelis, et al.
The Journal of Clinical Endocrinology and Metabolism|March 5, 2024
Pediatric Medullary Thyroid Carcinoma: Clinical Presentations and Long-Term Outcomes in 144 Patients Over 6 DecadesSarah G Hensley, Mimi I Hu, Roland L Bassett, et al.
Head & Neck|November 10, 2020
Neoadjuvant selpercatinib for advanced medullary thyroid cancerYelda Jozaghi, Mark Zafereo, Michelle D Williams, et al.
The Journal of Clinical Endocrinology and Metabolism|June 11, 2014
Denosumab for treatment of hypercalcemia of malignancyMimi I Hu, Ilya G Glezerman, Sophie Leboulleux, et al.
Thyroid : Official Journal of the American Thyroid Association|July 10, 2024
The Multi-Institutional Medullary Thyroid Cancer Collaborative Registry: Can a Rare Tumor Registry Accurately Represent the Real-World Patient Population?Thomas Szabo Yamashita, Sophia M Williams-Perez, Sara Ehsan, et al.
The Journal of Clinical Endocrinology and Metabolism|March 18, 2014
Role of salvage targeted therapy in differentiated thyroid cancer patients who failed first-line sorafenibRamona Dadu, Catherine Devine, Mike Hernandez, et al.
Surgery|December 10, 2025
The shifting landscape of germline RET pathogenic variants with the introduction of panel testingAmblessed E Onuma, Catherine M Skefos, Marcy E Richardson, et al.
Journal of Neuro-Oncology|April 14, 2026
A differentiated thyroid carcinoma-specific graded prognostic assessment for brain metastases: derivation in a 10,306-patient cohort and external validationHamza A Salim, Sarimar Agosto, Heba Al Qudah, et al.
JCO Oncology Practice|December 19, 2025
Increasing Access and Quality Care for Immune Checkpoint Inhibitor-Related Thyroid DysfunctionAnne K Brinkman, Amori Y Salami-Henry, Lori A Aaron-Brija, et al.
Endocrine|July 25, 2015
Preexisting adrenal masses in patients with adrenocortical carcinoma: clinical and radiological factors contributing to delayed diagnosisLevent Ozsari, Merve Kutahyalioglu, Khaled M Elsayes, et al.
Pageof 10